Ibopamine
- 1 lab
- Animals1
Outcomes
4Mortality
no changein rats1
1 study
Mortality
no changein rats1
Ibopamine has no effect on mortality in rats.
“Mortality during the study was not significantly different in treated and control groups”
Animals730 consecutive days
Reduced disease in aged rats treated chronically with ibopamine, a catecholaminergic drug
Neurobiology of aging1 Jan 1988
Squamous cell skin carcinoma
upin rats1
1 study
Squamous cell skin carcinoma
upin rats1
Ibopamine increases squamous cell skin carcinoma in rats.
“Squamous cell skin carcinoma was the only lesion that was significantly (p less than 0.05) increased in the treated groups.”
Animals730 consecutive days
Reduced disease in aged rats treated chronically with ibopamine, a catecholaminergic drug
Neurobiology of aging1 Jan 1988
Alopecia
downin rats1
1 study
Alopecia
downin rats1
Ibopamine decreases alopecia in rats.
“age-related alopecia and atrophy of the adrenal zona glomerulosa were retarded by ibopamine treatment”
Animals730 consecutive days
Reduced disease in aged rats treated chronically with ibopamine, a catecholaminergic drug
Neurobiology of aging1 Jan 1988
Neoplastic and nonneoplastic lesions
downin rats1
1 study
Neoplastic and nonneoplastic lesions
downin rats1
Ibopamine decreases neoplastic and nonneoplastic lesions in rats.
“Six neoplastic lesions (adrenal cortical, mammary, and pituitary adenoma, skin papilloma, pheochromocytoma and mammary adenocarcinoma) and five nonneoplastic lesions”
Animals730 consecutive days
Reduced disease in aged rats treated chronically with ibopamine, a catecholaminergic drug
Neurobiology of aging1 Jan 1988